Multiple Myeloma Concept

subject area of

• A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma  Journal Articles
• A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma  Journal Articles
• A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma  Journal Articles
• A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191  Journal Articles
• A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145  Journal Articles
• A pilot study of adherence to lenalidomide among older patients with multiple myeloma  Journal Articles
• A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7  Journal Articles
• A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial  Journal Articles
• A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients  Journal Articles
• A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial  Journal Articles
• Acute renal failure in multiple myeloma.  Journal Articles
• Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study  Journal Articles
• Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma  Journal Articles
• Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review  Journal Articles
• Antigen Interaction and Heat Inactivation Expose New Epitopes on Human IgE  Journal Articles
• Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents  Journal Articles
• Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study  Journal Articles
• Assessment of observer variation in measuring the radiographic vertebral index in patients with multiple myeloma  Journal Articles
• Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma  Conferences
• Autologous stem cell transplant in older patients (age ≥ 65) with newly diagnosed multiple myeloma: A systematic review and meta-analysis  Journal Articles
• Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age  Journal Articles
• Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial  Journal Articles
• Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.  Journal Articles
• Bortezomib in Multiple Myeloma: A Practice Guideline  Journal Articles
• Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma  Journal Articles
• Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma  Journal Articles
• COMPARISON OF FRAILTY SCORES IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA: A REVIEW  Journal Articles
• Canadian Perspective on Managing Multiple Myeloma during the COVID-19 Pandemic: Lessons Learned and Future Considerations  Journal Articles
• Canadian Perspective on Managing Multiple Myeloma during the COVID-19 Pandemic: Lessons Learned and Future Considerations.  Journal Articles
• Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study  Journal Articles
• Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma  Journal Articles
• Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute  Journal Articles
• Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma  Journal Articles
• Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease  Journal Articles
• Che‐1‐induced inhibition of mTOR pathway enables stress‐induced autophagy  Journal Articles
• Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma  Journal Articles
• Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma  Journal Articles
• DMG26  Journal Articles
• Daratumumab in newly diagnosed MM — incorporating lessons learnt from CASSIOPEIA, MAIA and beyond  Journal Articles
• Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells  Journal Articles
• Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma  Journal Articles
• Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma  Journal Articles
• Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study.  Journal Articles
• Disparities in treatment patterns and outcomes among younger and older adults with newly diagnosed multiple myeloma: A population-based study  Journal Articles
• Donor leukocyte infusions for multiple myeloma  Journal Articles
• Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study  Journal Articles
• Effect of Awareness of a Randomized Controlled Trial on Use of Experimental Therapy  Journal Articles
• Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.  Journal Articles
• Expression of Retrovirally Transduced IL-1 α in IL-6-Dependent B Cells: A Murine Model of Aggressive Multiple Myeloma  Journal Articles
• External validation of the FIRST trial’s simplified frailty score in a population-based cohort  Journal Articles
• Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials  Journal Articles
• First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium  Journal Articles
• Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis  Journal Articles
• Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment  Journal Articles
• Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies  Conferences
• Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT).  Journal Articles
• Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance  Journal Articles
• INDEPENDENT CLONAL ORIGIN OF COEXISTING CHRONIC LYMPHOCYTIC LEUKAEMIA AND MULTIPLE MYELOMA  Journal Articles
• Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high‐risk cytogenetics: A meta‐analysis of randomized controlled trials  Journal Articles
• Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma  Journal Articles
• Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis  Journal Articles
• Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis  Journal Articles
• Intra-articular solitary fibrous tumor of the knee  Journal Articles
• Just the facts: how to diagnose and manage patients with multiple myeloma in the emergency department?  Journal Articles
• LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling  Journal Articles
• Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial  Journal Articles
• Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells  Journal Articles
• Low‐depth sequencing for copy number abnormalities in multiple myeloma supersedes fluorescent in situ hybridization in scope and resolution  Journal Articles
• Lymphoma with hypercalcemia.  Journal Articles
• MRD negativity: considerations for older adults with multiple myeloma  Journal Articles
• Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis  Journal Articles
• Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis  Journal Articles
• Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?  Journal Articles
• Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34+ absolute counts and subsets  Journal Articles
• Oral bisphosphonates  Journal Articles
• Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma  Journal Articles
• Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database  Journal Articles
• Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study  Journal Articles
• Plasma Exchange When Myeloma Presents as Acute Renal Failure  Journal Articles
• Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response  Journal Articles
• Plasma exchange for myeloma kidney: cast(s) away?  Journal Articles
• Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study  Journal Articles
• Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)  Journal Articles
• Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2  Journal Articles
• Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy  Journal Articles
• Quadruplets in newly diagnosed transplant-ineligible multiple myeloma.  Journal Articles
• Quality of end‐of‐life care in multiple myeloma: A 13‐year analysis of a population‐based cohort in Ontario, Canada  Journal Articles
• Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.  Journal Articles
• Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database  Journal Articles
• Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database  Journal Articles
• Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database  Journal Articles
• Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis  Journal Articles
• Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”  Journal Articles
• Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant  Journal Articles
• Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era  Journal Articles
• Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin  Journal Articles
• Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis  Journal Articles
• Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database  Journal Articles
• Simplified frailty assessment tools: are we really capturing frailty or something else?  Journal Articles
• Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population‐based cohort study  Journal Articles
• Still high risk? A review of translocation t(14;16) in multiple myeloma  Journal Articles
• Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database  Journal Articles
• Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study  Journal Articles
• T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma  Journal Articles
• T-cell large granular lymphocytic leukemia and plasma cell disorders  Journal Articles
• Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database  Journal Articles
• Teclistamab in Relapsed or Refractory Multiple Myeloma  Journal Articles
• Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply.  Journal Articles
• Thalidomide‐prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10  Journal Articles
• The Evolving Field of Bone Imaging in Multiple Myeloma: Is it Time to Abandon Skeletal Surveys?  Journal Articles
• The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors  Journal Articles
• The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative  Journal Articles
• The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A Systematic Review  Conferences
• The relationship of CD34+ dosage and platelet recovery following high dose chemotherapy and autologous CD34+ reinfusion in multiple myeloma  Journal Articles
• The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?  Journal Articles
• The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review  Journal Articles
• The value of elevated gamma globulins in the diagnosis of monoclonal gammopathy and multiple myeloma  Journal Articles
• Therapy for relapsed multiple myeloma  Journal Articles
• Thrombosis is associated with inferior survival in multiple myeloma  Journal Articles
• Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?  Journal Articles
• Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper  Journal Articles
• Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study  Journal Articles
• Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline  Journal Articles
• Utility and prognostic value of ¹⁸F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma  Journal Articles
• Vesicular Stomatitis Virus: A Potential Therapeutic Virus for the Treatment of Hematologic Malignancy  Journal Articles
• Vitritis and retinal vasculitis as presenting signs of monoclonal gammopathy of unknown significance with progression to multiple myeloma  Journal Articles
• Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation  Journal Articles
• Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.  Journal Articles
• Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity  Journal Articles
• Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.  Journal Articles